Skip to main content
    F

    Flora Growth Corp (FLGC)

    Official site

    DRUG MANUFACTURERS - SPECIALTY & GENERIC

    $2.74
    +0.23 (+9.16%)

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Flora Growth Corp (FLGC) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2025. Financial statements from company filings, amounts in US dollars.

    Flora Growth reported revenue of $59.51M for the fiscal year ended Dec 31, 2024, down 21.8% from the year before. That year, net income was -$15.91M with a net margin of -26.7%, operating cash flow was -$5.03M and free cash flow was -$5.17M. The quarter ended Sep 30, 2025 had revenue of $9.75M and net income of -$6.66M.

    Revenue and Margins

    The operating margin was -26.3% in the fiscal year ended Dec 2024.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2024$59.51M-21.8%21.0%-26.3%-26.7%
    Dec 2023$76.07M+127.8%23.3%-66.2%-75.0%
    Dec 2022$33.40M+271.9%39.7%-141.4%-156.9%
    Dec 2021$8.98M+8371.7%27.0%-211.0%-237.9%
    Dec 2020$106.00KN/A67.0%-13475.5%-13367.9%
    Dec 2019N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2019 to Dec 2024

    Income Statement

    In the fiscal year ended Dec 2024, the net loss narrowed from the year before. In the quarter ended Sep 2025, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$59.51M$76.07M$33.40M$8.98M$106.00KN/A
    Cost of revenue$47.01M$58.33M$20.15M$6.55M$35.00K$25.86K
    Gross profit$12.50M$17.74M$13.25M$2.42M$71.00K-$25.86K
    Research and development$418.00K$62.00K$388.00K$132.00K$78.00K$21.04K
    Operating income-$15.64M-$50.35M-$47.22M-$18.95M-$14.28M-$2.82M
    Net income-$15.91M-$57.04M-$52.41M-$21.36M-$14.17M-$2.84M
    EBITDA-$15.10M-$45.87M-$17.87M-$18.19M-$14.19M-$2.80M
    Fiscal years ended Dec 2019 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Revenue$9.75M$14.80M$11.79M$13.33M$12.46M$15.68M$18.03M$17.98M$17.32M$21.46M$19.32M$11.49M
    Gross profit$335.00K$2.83M$2.89M$2.64M$2.84M$3.17M$3.85M$3.49M$4.94M$3.96M$5.35M$2.90M
    Operating income-$3.27M-$2.57M-$977.00K-$5.93M-$3.69M-$3.54M-$2.48M-$7.38M-$540.00K-$40.06M-$2.37M-$17.18M
    Net income-$6.66M-$2.41M-$758.00K-$6.13M-$3.77M-$2.63M-$3.37M-$10.11M$1.24M-$44.29M-$3.88M-$12.45M
    Last 12 quarters

    Balance Sheet

    As of Dec 2024, cash and equivalents exceeded short-term debt of $2.87M by $3.15M.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$26.23M$23.63M$80.99M$85.48M$19.45M$1.17M
    Current assets$19.76M$21.36M$31.16M$47.94M$17.63M$461.00K
    Cash and equivalents$6.02M$4.35M$8.94M$37.61M$15.52M$140.00K
    Total liabilities$21.72M$17.22M$24.57M$8.54M$3.20M$2.48M
    Short-term debt$2.87M$2.73M$2.20M$430.00K$329.00K$1.08M
    Long-term debtN/AN/AN/AN/A$69.00KN/A
    Shareholder equity$4.51M$6.40M$56.82M$77.17M$16.36M-$1.29M
    Fiscal years ended Dec 2019 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total assets$74.02M$22.67M$22.39M$26.23M$29.28M$30.08M$24.27M$23.63M$31.60M$30.48M$77.04M$80.99M
    Total liabilities$9.10M$18.64M$17.64M$21.72M$24.10M$21.81M$21.14M$17.22M$18.48M$20.25M$23.43M$24.57M
    Cash and equivalents$13.10M$1.47M$3.68M$6.02M$4.21M$6.13M$4.19M$4.35M$4.76M$1.78M$5.26M$8.94M
    Shareholder equity$64.92M$4.02M$4.76M$4.51M$4.25M$7.31M$3.14M$6.40M$14.32M$10.93M$54.05M$56.82M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2024.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$5.03M-$8.40M-$15.94M-$20.65M-$8.42M-$453.82K
    Capital expenditures$134.00K$163.00K$1.29M$3.98M$234.00K$140.17K
    Free cash flow-$5.17M-$8.56M-$17.23M-$24.63M-$8.65M-$593.99K
    Dividends paidN/AN/A$0$2.51M$0N/A
    Investing cash flow$203.00K-$234.00K-$15.80M-$14.55M-$2.16M-$431.23K
    Financing cash flow$6.49M$3.15M$4.41M$58.11M$25.82M$1.00M
    Fiscal years ended Dec 2019 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow$118.58K-$2.89M-$2.73M-$1.25M-$2.08M-$253.64K-$1.34M-$1.02M$514.96K-$3.49M-$4.32M-$2.10M
    Capital expenditures$428.15K$65.00K$24.00KN/A$20.46K$25.20K$88.00K$40.32KN/A$93.69K$102.00K$346.00K
    Free cash flow-$309.57K-$2.95M-$2.75MN/A-$2.10M-$278.84K-$1.43M-$1.06MN/A-$3.58M-$4.43M-$2.45M
    Last 12 quarters

    Frequently Asked Questions About FLGC

    What is Flora Growth's annual revenue?

    Flora Growth reported revenue of $59.51M for the fiscal year ended Dec 31, 2024.

    How fast is Flora Growth's revenue growing?

    Revenue was down 21.8% for the fiscal year ended Dec 31, 2024 compared with the year before. The compound annual revenue growth rate over 3 years was 87.8%.

    Is Flora Growth profitable?

    No. Flora Growth reported net income of -$15.91M for the fiscal year ended Dec 31, 2024, with a net margin of -26.7%.

    How much free cash flow does FLGC generate?

    For the fiscal year ended Dec 31, 2024, operating cash flow of -$5.03M minus capital expenditures of $134.00K produced free cash flow of -$5.17M.

    How much debt does Flora Growth have?

    The balance sheet dated Dec 31, 2024 reported short-term debt of $2.87M and cash and equivalents of $6.02M.